THE WIRE · UPDATED 2:42 PM MST No story is too small.
Statewide

Preclinical research at BYU may lead to development of low-cost immunotherapy

Utah.News 1 source cited Details

How this story was published

Published automatically from one public source cited; not yet reviewed by the desk. Tell us if something is wrong ↗

Source

ksl.com

Utah.News publishes every story with the sources it was built from. Questions or a correction: corrections@utah.news.

Single source Reported from one source.
Preclinical research at BYU may lead to development of low-cost immunotherapy
Photo via KSL
Read at KSL →

Utah News spotted this story published November 1, 2026 at KSL. Full coverage may follow as more sources report.

PROVO — Researchers at Brigham Young University are developing new technology that might help the body fight cancer. The technology, called MOTO-CAR, genetically engineers immune cells to recognize and attack cancer cells. In pre-clinical testing, researchers saw a 90% reduction in aggressive lung cancer cells in the lab within 24 hours, according to the university.

Report a problem with this story
What's off? Pick any that fit, or just write below.

Every report is read and checked against the story's sources. Your email, if you give one, is used only to contact you about this message and is never shown publicly. Please keep other personal details out of the text. Privacy